{"nctId":"NCT00691197","briefTitle":"Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear","startDateStruct":{"date":"2008-03"},"conditions":["Ametropia"],"count":246,"armGroups":[{"label":"Carboxymethylcellulose sodium and Glycerin","type":"EXPERIMENTAL","interventionNames":["Device: Carboxymethylcellulose sodium and Glycerin"]},{"label":"Carboxymethylcellulose sodium","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Carboxymethylcellulose sodium"]}],"interventions":[{"name":"Carboxymethylcellulose sodium and Glycerin","otherNames":["Optive™"]},{"name":"Carboxymethylcellulose sodium","otherNames":["Refresh Contacts®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adapted contact lens wearer\n\nExclusion Criteria:\n\n* Monovision lens wearer, ocular or systemic disease, pregnant or planning to become pregnant","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Best Corrected Visual Acuity","description":"Percentage of Subjects Tabulated by Changes in Line Number at Day 90 from Baseline; Visual Acuity measured by LogMar reported as Snellen equivalents. Better: an increase of 2 lines or more in at least one eye; No Change: a change less than +/- 2 lines in both eyes; Worse: a decrease of 2 lines or more in at least one eye.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.65","spread":null},{"groupId":"OG001","value":"1.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.06","spread":null},{"groupId":"OG001","value":"98.67","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.29","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"POST_HOC","title":"Patient Acceptability","description":"A questionnaire was administered to all patients to evaluate the acceptability of the Rewetting Drops (RD) with use with Contact Lenses (CL). Table below shows the percentage of participants responding either \"Agree\" or \"Strongly Agree\" at day 90. Number of participants answering question is indicated as (number of Test subjects/number of Control subjects)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.5","spread":null},{"groupId":"OG001","value":"82.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78.8","spread":null},{"groupId":"OG001","value":"84.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.0","spread":null},{"groupId":"OG001","value":"54.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.6","spread":null},{"groupId":"OG001","value":"62.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.6","spread":null},{"groupId":"OG001","value":"44.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85.7","spread":null},{"groupId":"OG001","value":"81.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.0","spread":null},{"groupId":"OG001","value":"41.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.4","spread":null},{"groupId":"OG001","value":"68.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.5","spread":null},{"groupId":"OG001","value":"43.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Corneal Staining","description":"Corneal staining of greater or equal to grade 2 at day 90. Grading scale: 0 = None Present; 1 = Trace Finding; 2 = Mild Finding; 3 = Moderate Finding; 4 = Severe Finding","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"POST_HOC","title":"Patient Preference","description":"Percentage of patients who used pre-study rewetting drops and answered \"Agree\" or \"Strongly Agree\" when asked if they preferred the study drops (SD) over their pre-study drops(PSD).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.2","spread":null},{"groupId":"OG001","value":"41.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.2","spread":null},{"groupId":"OG001","value":"34.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":166},"commonTop":["Dry eye","Eye irritation","Eye discharge","Eye pruritus","Asthenopia"]}}}